www.usynova.com

Website unreachable since Oct 27, 2026

Usynova Biopharmaceuticals develops small molecule targeted therapies, recombinant proteins, and monoclonal antibodies specifically for cancer and autoimmune diseases. The company focuses on addressing unmet clinical needs by creating novel drugs with proprietary intellectual property to enhance treatment efficacy and improve patient outcomes.

Traction –/10

HQ unknown

Biotechnology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Usynova Biopharmaceuticals develops small molecule targeted therapies, recombinant proteins, and monoclonal antibodies specifically for cancer and autoimmune diseases. The company focuses on addressing unmet clinical needs by creating novel drugs with proprietary intellectual property to enhance treatment efficacy and improve patient outcomes.